Cargando…

Tretatment Approach of Nontransplant Patients with Multiple Myeloma

Multiple myeloma is still an incurable disease with pattern of regression and remission followed by multiple relapses raising from the residual myeloma cells surviving even in the patients who achieve complete clinical response to treatment. In recent years there is a huge improvement in treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krstevska, Svetlana B., Sotirova, Tatjana, Balkanov, Trajan, Genadieva-Stavric, Sonja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AVICENA, d.o.o., Sarajevo 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272840/ https://www.ncbi.nlm.nih.gov/pubmed/25568637 http://dx.doi.org/10.5455/msm.2014.26.348-351

Ejemplares similares

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015)

Hairy Cell Leukemia Treatment: Where We Are Now?
por: Krstevska, Svetlana, et al.
Publicado: (2011)

Adverse Effects of Thalidomide Administration, in Patients with Myeloma Multiplex?
por: Svetlana Balkanov, Krstevska, et al.
Publicado: (2014)

Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes
por: Sotirova, Tatjana, et al.
Publicado: (2014)

Determination of the Diagnostic Values of Asymmetric Dimethylarginine as an Indicator for Evaluation of the Endothelial Dysfunction in Patients with Rheumatoid Arthritis
por: Spasovski, Dejan, et al.
Publicado: (2013)

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
por: Qerimi, Vjollca, et al.
Publicado: (2018)

Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients With Newly Diagnosed Multiple Myeloma
por: Bennink, M. Christine, et al.
Publicado: (2022)

Disseminated Cryptococcal Disease in Non-HIV, Nontransplant Patient
por: AlMutawa, F., et al.
Publicado: (2016)

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
por: Darkovska-Serafimovska, Marija, et al.
Publicado: (2018)

1251. Determinants of Infection at a Nontransplanting Cardiothoracic LVAD Program
por: Milgrom, Alexander, et al.
Publicado: (2019)

Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
por: Grubovic, Rada M., et al.
Publicado: (2017)

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
por: Groen, Kazimierz, et al.
Publicado: (2023)

Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States
por: Medhekar, Rohan, et al.
Publicado: (2022)

Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable
por: Razia, Deepika, et al.
Publicado: (2022)

Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)

Invasive Nocardiosis in Transplant and Nontransplant Patients: 20-Year Experience in a Tertiary Care Center
por: Harris, Dana M., et al.
Publicado: (2021)

Investigation of Infectious Disease Risks Associated With a Nontransplant Anatomical Donation Center — Arizona, 2014
por: de Perio, Marie A., et al.
Publicado: (2014)

Modest but impactful: Commentary on immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Lindeman, Jan H.
Publicado: (2022)

Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019
por: Aziz, Fahad, et al.
Publicado: (2020)

Determination of Acyclovir in Human Plasma Samples by HPLC Method with UV Detection: Application to Single-Dose Pharmacokinetic Study
por: Zendelovska, Dragica, et al.
Publicado: (2015)

Radiolabeled tirofiban – a potential radiopharmaceutical for detection of deep venous thrombosis
por: Darkovska-Serafimovska, Marija, et al.
Publicado: (2016)

NonHodgkin's Lymphoma with Peritoneal Localization
por: Curakova, E., et al.
Publicado: (2014)

Immunotherapeutic and Targeted Approaches in Multiple Myeloma
por: Nadeem, Omar, et al.
Publicado: (2020)

Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers
por: Cascino, Thomas M., et al.
Publicado: (2022)

Does Cannabis Extract Obtained From Cannabis Flowers With Maximum Allowed Residual Level of Aflatoxins and Ochratoxin a Have an Impact on Human Safety and Health?
por: Serafimovska, Tijana, et al.
Publicado: (2021)

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
por: Markus, Efrat, et al.
Publicado: (2020)

Cell-based immunotherapy approaches for multiple myeloma
por: Kriegsmann, Katharina, et al.
Publicado: (2018)

Living-donor parathyroid allotransplantation for therapy-refractory postsurgical persistent hypoparathyroidism in a nontransplant recipient – three year results: a case report
por: Agha, Ayman, et al.
Publicado: (2016)

Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma
por: Swan, Dawn, et al.
Publicado: (2019)

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
por: Dimopoulos, Meletios A., et al.
Publicado: (2020)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools
por: Krstevska, Aleksandra, et al.
Publicado: (2022)

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2021)

A study of patients with cirrhosis admitted to nontransplant general intensive care in the UK: prevalence, case mix, outcomes and evaluation of critical illness and disease-specific scoring systems
por: Thomson, SJ, et al.
Publicado: (2010)

Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
por: Bobin, Arthur, et al.
Publicado: (2020)

Multiple myeloma/hypercalcemia
por: Oyajobi, Babatunde O
Publicado: (2007)

Immunotherapy for Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2019)

Integrins in multiple myeloma
por: Hosen, Naoki
Publicado: (2020)

Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020)

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7tcjqdo4706bt6v1o3gq2ir9km